Reproductive characteristics in relation to ovarian cancer risk by histologic pathways

被引:87
作者
Merritt, M. A. [1 ,2 ,3 ]
De Pari, M. [2 ]
Vitonis, A. F. [2 ]
Titus, L. J. [4 ]
Cramer, D. W. [1 ,2 ]
Terry, K. L. [1 ,2 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol,OB GYN Epidemiol Ctr, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[4] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03756 USA
关键词
ovarian cancer; histology; reproduction; risk factors; type I; II; CLEAR-CELL CARCINOMA; SEROUS CARCINOMA; INCESSANT OVULATION; FALLOPIAN-TUBE; EPIDEMIOLOGIC EVIDENCE; GENE-MUTATIONS; UNITED-STATES; MATERNAL RISK; ENDOMETRIOSIS; ARID1A;
D O I
10.1093/humrep/des466
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Do reproductive risk factor associations differ across subgroups of invasive epithelial ovarian cancer (EOC) defined by the dualistic model (type I/II) or a histologic pathway-based classification? Associations with parity, history of endometriosis, tubal ligation and hysterectomy were found to differ in the context of the type I/II and the histologic pathways classification of ovarian cancer. Shared molecular alterations and candidate precursor lesions suggest that tumor histology and grade may be used to classify ovarian tumors into likely etiologic pathways. This casecontrol study included 1571 women diagnosed with invasive EOC and 2100 population-based controls that were enrolled from 1992 to 2008. Reproductive risk factors as well as other putative risk factors for ovarian cancer were assessed through in-person interviews. Eligible cases were diagnosed with incident ovarian cancer, were aged 18 and above and resided in eastern Massachusetts or New Hampshire, USA. Controls were identified through random digit dialing, drivers license and town resident lists and were frequency matched with the cases based on age and study center. We used polytomous logistic regression to estimate odds ratios (ORs) and 95 confidence intervals (CIs) for type I/II EOC or using a pathway-based grouping of histologic subtypes. In multivariate analyses, we observed that having a history of endometriosis (OR 1.92, 95 CI: 1.362.71) increased the risk for a type I tumor. Factors that were strongly inversely associated with risk for a type I tumor included parity (3 versus 0 children, OR 0.15, 95 CI: 0.110.21), having a previous tubal ligation (OR 0.40, 95 CI: 0.260.60) and more weakly hysterectomy (OR 0.71, 95 CI: 0.451.13). In analyses of histologic pathways, parity (3 versus 0 children, OR 0.13, 95 CI: 0.100.18) and having a previous tubal ligation (OR 0.41, 95 CI: 0.280.60) or hysterectomy (OR 0.54, 95 CI: 0.340.86) were inversely associated with risk of endometrioid/clear cell tumors. Having a history of endometriosis strongly increased the risk for endometrioid/clear cell tumors (OR 2.41, 95 CI: 1.783.26). We did not observe significant differences in the risk associations across these tumor classifications for age at menarche, menstrual cycle length or infertility. A potential limitation of this study is that dividing the cases into subgroups may limit the power of these analyses, particularly for the less common tumor types. Since cases were enrolled after their diagnosis, it is possible that the most aggressive cases were not included in the study. This study provides insights about the role of reproductive factors in relation to risk of pathway-based subgroups of ovarian cancer that with further confirmation may assist with the development of improved strategies for the prevention of these different tumor types. This research is funded by grants from the National Cancer Institute, the Department of Defense Ovarian Cancer Research Program and the Ovarian Cancer Research Fund. The authors have no competing interests to declare. Not applicable.
引用
收藏
页码:1406 / 1417
页数:12
相关论文
共 59 条
[1]   PARITY, AGE AT FIRST CHILDBIRTH, AND RISK OF OVARIAN-CANCER [J].
ADAMI, HO ;
HSIEH, CC ;
LAMBE, M ;
TRICHOPOULOS, D ;
LEON, D ;
PERSSON, I ;
EKBOM, A ;
JANSON, PO .
LANCET, 1994, 344 (8932) :1250-1254
[2]   Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary [J].
Ahmed, Ashour Ahmed ;
Etemadmoghadam, Dariush ;
Temple, Jillian ;
Lynch, Andy G. ;
Riad, Mohamed ;
Sharma, Raghwa ;
Stewart, Colin ;
Fereday, Sian ;
Caldas, Carlos ;
DeFazio, Anna ;
Bowtell, David ;
Brenton, James D. .
JOURNAL OF PATHOLOGY, 2010, 221 (01) :49-56
[3]   Gender of offspring and maternal risk of invasive epithelial ovarian cancer [J].
Baik, Inkyung ;
Lambe, Mats ;
Liu, Qin ;
Cnattingius, Sven ;
Mucci, Lorelei A. ;
Riman, Tomas ;
Ekbom, Anders ;
Adami, Hans-Olov ;
Hsieh, Chung-Cheng .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (11) :2314-2320
[4]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[5]   Mechanisms of Disease Endometriosis [J].
Bulun, Serdar E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (03) :268-279
[6]   Mutation of the PIK3CA gene in ovarian and breast cancer [J].
Campbell, IG ;
Russell, SE ;
Choong, DYH ;
Montgomery, KG ;
Ciavarella, ML ;
Hooi, CSF ;
Cristiano, BE ;
Pearson, RB ;
Phillips, WA .
CANCER RESEARCH, 2004, 64 (21) :7678-7681
[7]   Risk factors for ovarian cancer histotypes [J].
Chiaffarino, Francesca ;
Parazzini, Fabio ;
Bosetti, Cristina ;
Franceschi, Silvia ;
Talamini, Renato ;
Canzonieri, Vincenzo ;
Montella, Maurizio ;
Ramazzotti, Valerio ;
Franceschi, Silvia ;
La Vecchia, Carlo .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) :1208-1213
[8]   Tubal ligation and the risk of ovarian cancer: review and meta-analysis [J].
Cibula, D. ;
Widschwendter, M. ;
Majek, O. ;
Dusek, L. .
HUMAN REPRODUCTION UPDATE, 2011, 17 (01) :55-67
[9]  
CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717
[10]  
Cuatrecasas M, 1998, CANCER-AM CANCER SOC, V82, P1088